Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis.
DHA
Experimental colitis
IBD
Inflammation
Intestinal barrier
Journal
European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704
Informations de publication
Date de publication:
06 Aug 2024
06 Aug 2024
Historique:
received:
04
10
2023
accepted:
05
07
2024
medline:
6
8
2024
pubmed:
6
8
2024
entrez:
6
8
2024
Statut:
aheadofprint
Résumé
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic gastrointestinal disorders associated with significant morbidity and complications. This study investigates the therapeutic potential of docosahexaenoic acid (DHA) in a trinitrobenzene sulfonic acid (TNBS) induced colitis model, focusing on inflammation, oxidative stress, and intestinal membrane permeability. Wistar albino rats were divided into Control, Colitis, and Colitis + DHA groups (n = 8-10/group). The Colitis and Colitis + DHA groups received TNBS intrarectally, while the Control group received saline. DHA (600 mg/kg/day) or saline was administered via gavage for six weeks. Macroscopic and microscopic evaluations of colon tissues were conducted. Parameters including occludin and ZO-1 expressions, myeloperoxidase (MPO) activity, malondialdehyde (MDA), glutathione (GSH), total antioxidant status (TAS), total oxidant status (TOS), Interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α) levels were measured in colon tissues. Colitis induction led to significantly higher macroscopic and microscopic damage scores, elevated TOS levels, reduced occludin and ZO-1 intensity, decreased mucosal thickness, and TAS levels compared to the Control group (p < 0.001). DHA administration significantly ameliorated these parameters (p < 0.001). MPO, MDA, TNF-α, and IL-6 levels were elevated in the Colitis group but significantly reduced in the DHA-treated group (p < 0.001 for MPO, MDA; p < 0.05 for TNF-α and IL-6). DHA demonstrated antioxidant and anti-inflammatory effects by reducing reactive oxygen species production, enhancing TAS capacity, preserving GSH content, decreasing proinflammatory cytokine levels, preventing neutrophil infiltration, reducing shedding in colon epithelium, and improving gland structure and mucosal membrane integrity. DHA also upregulated the expressions of occludin and ZO-1, critical for barrier function. Thus, DHA administration may offer a therapeutic strategy or supplement to mitigate colitis-induced adverse effects.
Identifiants
pubmed: 39105785
doi: 10.1007/s00394-024-03468-x
pii: 10.1007/s00394-024-03468-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Hendrickson BA et al (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15:79–94. https://doi.org/10.1128/CMR.15.1.79-94.2002
doi: 10.1128/CMR.15.1.79-94.2002
pubmed: 11781268
pmcid: 118061
Kaplan GG (2015) The global burden of IBD: from 2015 to 2025. Nat Reviews Gastroenterol Hepatol 12:720–727. https://doi.org/10.1038/nrgastro.2015.150
doi: 10.1038/nrgastro.2015.150
Singh S et al (2020) Management of inflammatory bowel diseases in special populations: obese, old, or obstetric. Clin Gastroenterol Hepatol 18:1367–1380. https://doi.org/10.1016/j.cgh.2019.11.009
doi: 10.1016/j.cgh.2019.11.009
pubmed: 31712084
Kaser A, Blumberg RS (2008) Adaptive immunity in inflammatory bowel disease: state of the art. Curr Opin Gastroenterol 24:455–461. https://doi.org/10.1097/MOG.0b013e328304d60d
doi: 10.1097/MOG.0b013e328304d60d
pubmed: 18622159
Maunder RG et al (2005) Attachment insecurity moderates the relationship between disease activity and depressive symptoms in ulcerative colitis. Inflamm Bowel Dis 11:919–926. https://doi.org/10.1097/01.mib.0000179468.78876.2d
doi: 10.1097/01.mib.0000179468.78876.2d
pubmed: 16189422
Saraggi D et al (2017) The molecular landscape of colitis-associated carcinogenesis. Dig Liver Disease 49:326–330. https://doi.org/10.1016/j.dld.2016.12.011
doi: 10.1016/j.dld.2016.12.011
Muthas D et al (2017) Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications. Scand J Gastroenterol 52:125–135. https://doi.org/10.1080/00365521.2016.1235224
doi: 10.1080/00365521.2016.1235224
pubmed: 27610713
Tian T et al (2017) Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxidative Med Cell Longev 2017. https://doi.org/10.1155/2017/4535194
Hashimoto M et al (2017) Docosahexaenoic acid: one molecule diverse functions. Crit Rev Biotechnol 37:579–597. https://doi.org/10.1080/07388551.2016.1207153
doi: 10.1080/07388551.2016.1207153
pubmed: 27426008
Mao X et al (2019) Benzoic acid used as food and feed additives can regulate gut functions. Biomed Res Int 2019. https://doi.org/10.1155/2019/5721585
Sung MK et al (2011) Obesity-induced metabolic stresses in breast and colon cancer. Ann N Y Acad Sci 1229:61–68. https://doi.org/10.1111/j.1749-6632.2011.06094.x
doi: 10.1111/j.1749-6632.2011.06094.x
pubmed: 21793840
Clayburgh DR et al (2004) A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 84:282–291. https://doi.org/10.1038/labinvest.3700050
doi: 10.1038/labinvest.3700050
pubmed: 14767487
González C et al (2013) Epithelial cell culture from human adenoids: a functional study model for ciliated and secretory cells. Biomed Res Int 2013:478713. https://doi.org/10.1155/2013/478713
Lien EL (2009) Toxicology and safety of DHA. Prostaglandins Leukot Essent Fat Acids 81:125–132. https://doi.org/10.1016/j.plefa.2009.05.004
doi: 10.1016/j.plefa.2009.05.004
Morris GP et al (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795–803 PMID: 2914642
de Santos O, R. et al (2021) L-glutamine and physical exercise prevent intestinal inflammation and oxidative stress without improving gastric dysmotility in rats with ulcerative colitis. Inflammation 44:617–632. https://doi.org/10.1007/s10753-020-01361-3
doi: 10.1007/s10753-020-01361-3
pubmed: 33128666
Wallace JL et al (1995) Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. J Pharmacol Toxicol Methods 33:237–239. https://doi.org/10.1016/1056-8719(95)00001-x
doi: 10.1016/1056-8719(95)00001-x
pubmed: 8527832
Yumru M et al (2009) Oxidative imbalance in bipolar disorder subtypes: a comparative study. Prog Neuropsychopharmacol Biol Psychiatry 33:1070–1074. https://doi.org/10.1016/j.pnpbp.2009.06.005
doi: 10.1016/j.pnpbp.2009.06.005
pubmed: 19527764
Kosecik M et al (2005) Increased oxidative stress in children exposed to passive smoking. Int J Cardiol 100:61–64. https://doi.org/10.1016/j.ijcard.2004.05.069
doi: 10.1016/j.ijcard.2004.05.069
pubmed: 15820286
Harma M, Erel O (2003) Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 133. https://doi.org/10.4414/smw.2003.10397
Kolgazi M et al (2013) The role of cholinergic anti-inflammatory pathway in acetic acid-induced colonic inflammation in the rat. Chemico-Biol Interact 205:72–80. https://doi.org/10.1016/j.cbi.2013.06.009
doi: 10.1016/j.cbi.2013.06.009
Pazar A et al (2016) The neuroprotective and anti-apoptotic effects of melatonin on hemolytic hyperbilirubinemia‐induced oxidative brain damage. J Pineal Res 60:74–83. https://doi.org/10.1111/jpi.12292
doi: 10.1111/jpi.12292
pubmed: 26511903
Necefli A et al (2006) The effect of melatonin on TNBS-induced colitis. Dig Dis Sci 51:1538–1545. https://doi.org/10.1007/s10620-005-9047-3
doi: 10.1007/s10620-005-9047-3
pubmed: 16927145
Kawashima K, Fujii T (2003) The lymphocytic cholinergic system and its biological function. Life Sci 72:2101–2109. https://doi.org/10.1016/s0024-3205(03)00068-7
doi: 10.1016/s0024-3205(03)00068-7
pubmed: 12628464
Tayebati SK et al (2002) Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J Neuroimmunol 132:147–155. https://doi.org/10.1016/s0165-5728(02)00325-9
doi: 10.1016/s0165-5728(02)00325-9
pubmed: 12417445
Kruidenier L et al (2003) Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Radic Biol Med 34:753–765. https://doi.org/10.1016/s0891-5849(02)01426-0
doi: 10.1016/s0891-5849(02)01426-0
pubmed: 12633752
Han W et al (2006) Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis 12:1044–1052. https://doi.org/10.1097/01.mib.0000235101.09231.9e
doi: 10.1097/01.mib.0000235101.09231.9e
pubmed: 17075345
Zhang Y et al (2019) DHA protects against monosodium urate-induced inflammation through modulation of oxidative stress. Food Funct 10:4010–4021. https://doi.org/10.1039/c9fo00573k
doi: 10.1039/c9fo00573k
pubmed: 31214670
Merzouk SA et al (2008) N-3 polyunsaturated fatty acids modulate in-vitro T cell function in type I diabetic patients. Lipids 43:485–497. https://doi.org/10.1007/s11745-008-3176-3
doi: 10.1007/s11745-008-3176-3
pubmed: 18392872
Casañas-Sánchez V et al (2015) Docosahexaenoic (DHA) modulates phospholipid-hydroperoxide glutathione peroxidase (Gpx4) gene expression to ensure self-protection from oxidative damage in hippocampal cells. Front Physiol 6:203. https://doi.org/10.3389/fphys.2015.00203
doi: 10.3389/fphys.2015.00203
pubmed: 26257655
pmcid: 4510835
Joo M et al (2015) Anti-inflammatory effects of flavonoids on TNBS-induced colitis of rats. Korean J Physiol Pharmacol 19:43–50. https://doi.org/10.4196/kjpp.2015.19.1.43
doi: 10.4196/kjpp.2015.19.1.43
pubmed: 25605996
Mårtensson J et al (1990) Glutathione is required for intestinal function. Proc Natl Acad Sci 87:1715–1719. https://doi.org/10.1073/pnas.87.5.1715
doi: 10.1073/pnas.87.5.1715
pubmed: 2308931
pmcid: 53553
Guan G, Lan S (2018) Implications of antioxidant systems in inflammatory bowel disease. Biomed Res Int 2018. https://doi.org/10.1155/2018/1290179
Horton A et al (1987) Lipid peroxidation and mechanisms of toxicity. CRC Crit Reviews Toxicol 18:27–79. https://doi.org/10.3109/10408448709089856
doi: 10.3109/10408448709089856
Seljeskog E et al (2006) A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS). A comparison with a commercially available kit. Clin Biochem 39:947–954. https://doi.org/10.3109/10408448709089856
doi: 10.3109/10408448709089856
pubmed: 16781699
Yui K et al (2021) Lipid peroxidation with implication of organic pollution in autistic behaviors. Cureus 13:e14188. https://doi.org/10.7759/cureus.14188
doi: 10.7759/cureus.14188
pubmed: 33936898
pmcid: 8083076
Jiang W et al (2021) Docosahexaenoic acid activates the Nrf2 signaling pathway to alleviate impairment of spleen cellular immunity in intrauterine growth restricted rat pups. Saudi J Biol Sci 28:4987–4993. https://doi.org/10.1016/j.sjbs.2021.05.058
doi: 10.1016/j.sjbs.2021.05.058
pubmed: 34466073
pmcid: 8381073
Romeo Villadóniga S et al (2018) Effects of oral supplementation with Docosahexaenoic Acid (DHA) plus antioxidants in pseudoexfoliative glaucoma: a 6-month open-label randomized trial. J Ophthalmol 2018. https://doi.org/10.1155/2018/8259371
Maloy KJ, Powrie F (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474:298–306. https://doi.org/10.1038/nature10208
doi: 10.1038/nature10208
pubmed: 21677746
Zhu H, Li YR (2012) Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Experimental Biology Med 237:474–480. https://doi.org/10.1258/ebm.2011.011358
doi: 10.1258/ebm.2011.011358
Ullman TA, Itzkowitz SH (2011) Intestinal inflammation and cancer. Gastroenterology 140:1807–1816. e1801. https://doi.org/10.1053/j.gastro.2011.01.057
doi: 10.1053/j.gastro.2011.01.057
pubmed: 21530747
He J et al (2017) Recovery of corneal sensitivity and increase in nerve density and wound healing in diabetic mice after PEDF plus DHA treatment. Diabetes 66:2511–2520. https://doi.org/10.2337/db17-0249
doi: 10.2337/db17-0249
pubmed: 28592408
pmcid: 5566302
Nordgren TM et al (2014) The omega-3 fatty acid docosahexaenoic acid attenuates organic dust-induced airway inflammation. Nutrients 6:5434–5452. https://doi.org/10.3390/nu6125434
doi: 10.3390/nu6125434
pubmed: 25436433
pmcid: 4276977
Pineda-Peña EA et al (2018) Participation of the anti-inflammatory and antioxidative activity of docosahexaenoic acid on indomethacin-induced gastric injury model. Eur J Pharmacol 818:585–592. https://doi.org/10.3390/nu6125434
doi: 10.3390/nu6125434
pubmed: 29154839
Chen J et al (2013) Docosahexaenoic acid (DHA) attenuated paraquat induced lung damage in mice. Inhal Toxicol 25:9–16. https://doi.org/10.3109/08958378.2012.750405
doi: 10.3109/08958378.2012.750405
pubmed: 23293968
Sharon P, Stenson WF (1984) Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86:453–460. https://doi.org/10.1016/S0016-5085(84)80015-3
doi: 10.1016/S0016-5085(84)80015-3
pubmed: 6319219
Wen J et al (2016) The potential mechanism of Bawei Xileisan in the treatment of dextran sulfate sodium-induced ulcerative colitis in mice. J Ethnopharmacol 188:31–38. https://doi.org/10.1016/j.jep.2016.04.054
doi: 10.1016/j.jep.2016.04.054
pubmed: 27132718
Gisbert JP, Chaparro M (2020) Predictors of primary response to biologic treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in patients with inflammatory bowel disease: from basic science to clinical practice. J Crohns Colitis 14:694–709. https://doi.org/10.1093/ecco-jcc/jjz195
doi: 10.1093/ecco-jcc/jjz195
pubmed: 31777929
Kawachi S et al (2000) Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice. Am J Physiology-Gastrointestinal Liver Physiol 278:G734–G743. https://doi.org/10.1152/ajpgi.2000.278.5.G734
doi: 10.1152/ajpgi.2000.278.5.G734
Ye M et al (2020) Deletion of IL-6 exacerbates colitis and induces systemic inflammation in IL-10-deficient mice. J Crohns Colitis 14:831–840. https://doi.org/10.1093/ecco-jcc/jjz176
doi: 10.1093/ecco-jcc/jjz176
pubmed: 31679013
Glehen O et al (2003) Enteral immunotherapy in the treatment of chronic enterocolitis in interleukin-10-deficient mice. Hepatogastroenterology 50:670–675 PMID: 12828057
pubmed: 12828057
Varelis P, Melton L, Shahidi F (2018) Phospholipids. Encyclopedia of food chemistry. Elsevier, pp 214–217
Hersberger M (2010) Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins. Clin Chem Lab Med 48:1063–1073. https://doi.org/10.1515/CCLM.2010.212
doi: 10.1515/CCLM.2010.212
pubmed: 20441482
Liu T et al (2017) NF-κB signaling in inflammation. Signal Transduct Target Therapy 2:1–9. https://doi.org/10.1038/sigtrans.2017.23
doi: 10.1038/sigtrans.2017.23
Qiu S et al (2020) Maresin 1 alleviates dextran sulfate sodium-induced ulcerative colitis by regulating NRF2 and TLR4/NF-kB signaling pathway. Int Immunopharmacol 78:106018. https://doi.org/10.1016/j.intimp.2019.106018
doi: 10.1016/j.intimp.2019.106018
pubmed: 31780371
Krug SM et al (2014) Tight junction, selective permeability, and related diseases. Semin Cell Dev Biol 36:166–176. https://doi.org/10.1016/j.semcdb.2014.09.002
doi: 10.1016/j.semcdb.2014.09.002
pubmed: 25220018
Bruewer M et al (2006) Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci 1072:242–252. https://doi.org/10.1196/annals.1326.017
doi: 10.1196/annals.1326.017
pubmed: 17057204
Weber C, Turner J (2007) Inflammatory bowel disease: is it really just another break in the wall? Gut 56:6–8. https://doi.org/10.1196/annals.1326.017
doi: 10.1196/annals.1326.017
pubmed: 17172583
pmcid: 1856658
Furuse M et al (2002) Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 156:1099–1111. https://doi.org/10.1083/jcb.200110122
doi: 10.1083/jcb.200110122
pubmed: 11889141
pmcid: 2173463
Marin ML et al (1983) A freeze fracture study of Crohn’s disease of the terminal ileum: changes in epithelial tight junction organization. Am J Gastroenterol 78:537–547. PMID: 6613965
Ghosh S et al (2021) Regulation of intestinal barrier function by microbial metabolites. Cell Mol Gastroenterol Hepatol 11:1463–1482. https://doi.org/10.1016/j.jcmgh.2021.02.007
doi: 10.1016/j.jcmgh.2021.02.007
pubmed: 33610769
pmcid: 8025057
Hartsock A, Nelson WJ (2008) Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 1778:660–669. https://doi.org/10.1016/j.bbamem.2007.07.012
doi: 10.1016/j.bbamem.2007.07.012
pubmed: 17854762
Kucharzik T et al (2001) Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 159:2001–2009. https://doi.org/10.1016/S0002-9440(10)63051-9
doi: 10.1016/S0002-9440(10)63051-9
pubmed: 11733350
pmcid: 1850599
Li Q et al (2008) n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines. Mol Immunol 45:1356–1365. https://doi.org/10.1016/j.molimm.2007.09.003
doi: 10.1016/j.molimm.2007.09.003
pubmed: 17936906
Zhao J et al (2015) DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function. Br J Nutr 114:181–188. https://doi.org/10.1017/S0007114515001294
doi: 10.1017/S0007114515001294
pubmed: 26104043
Chelakkot C et al (2018) Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med 50:1–9. https://doi.org/10.1038/s12276-018-0126-x
doi: 10.1038/s12276-018-0126-x
pubmed: 30115904